The nation of Zimbabwe has turned down a major American healthcare agreement worth 367 million US dollars (272 million pounds) over five years due to the United States' demand for sensitive information.
This rejection came to light after a official document from December was disclosed, indicating that Head of State Emmerson Mnangagwa deemed the deal was "lopsided".
An official representative has since stated that the US was demanding access to genetic material for scientific study and profit while refused to share the resulting advantages from any future medical innovations.
"We must now begin the challenging and unfortunate task of scaling back our health assistance in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont in a statement.
The US Embassy indicated the US had furnished more than $1.9bn for health programmes to Zimbabwe over the last two decades.
A doctors' association in Zimbabwe has urged further talks to find a deal acceptable to both sides so the nation's vital HIV treatment initiative can be sustained.
Wider Background
Zimbabwe's decision comes after a comparable case in Kenya, where a court halted a related health funding agreement after legal challenges were raised about the security of Kenyans' health data.
Since returning to office last year, US President Donald Trump has drastically cut overseas assistance and shut down the key foreign aid agency.
USAID had overseen assistance for the American government, but Trump argued its expenditure was "wasteful" and his government was pursuing government-to-government agreements to enhance transparency and responsibility.
Based on statements, Sixteen nations in Africa have so far signed these new agreements, constituting more than $18.3bn of fresh investment.
Specifics of the Declined Deal
This assistance for Zimbabwe would have gone towards "tackling HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We are confident this partnership could have provided significant benefits for the people of Zimbabwe, especially the 1.2 million currently receiving antiretroviral therapy through US-supported programmes," the Ambassador commented.
However, government spokesperson Nick Mangwana said the proposed deal was "unequal".
"Our nation was requested to surrender its biological resources and data for a long time, with no corresponding promise of access to any medical innovations – such as vaccines, diagnostics, or treatments – that could result from that shared data," he stated.
"In essence, our country would supply the basic resources for medical research without any certainty that the resulting innovations would be available to our citizens if a future pandemic arise."
National Interest and Global Health
Mangwana further pointed out that the American exit from the World Health Organization (WHO) and its push of bilateral health agreements were upending frameworks previously set up through the global organization.
Mangwana gave as an example its Pathogen Access and Benefit Sharing framework created to deal with potential pandemics.
"This framework is designed to ensure that when a nation provides its samples, the benefits – such as medicines and cures – are shared equitably, not commercialised exclusively by those with the resources to develop them."
The government's concerns over the US deal "must not be interpreted as hostility towards the US," Mangwana stressed.
"We welcome ongoing discussions with our US partners on how future co-operation might be structured in a manner that respects the sovereignty and interests of both nations."
Medical Community Reaction
A leading public health body said it recognised the government's concerns, but suggested that talks need to persist given that a large portion of the country's Aids initiatives were funded by external financing.
"If technical issues arise, such as those involving information security or implementation frameworks, these can often be resolved through technical clarification and mutually agreed protections," the group added.
The situation highlights the continuing tensions between receiving vital foreign assistance and protecting national sovereignty in an increasingly data-driven world.